Centre for Innovation & Precision Eye Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Ophthalmology, National University Hospital, National University Health System, Singapore.
Centre for Innovation & Precision Eye Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Asia Pac J Ophthalmol (Phila). 2024 Sep-Oct;13(5):100098. doi: 10.1016/j.apjo.2024.100098. Epub 2024 Oct 2.
The objective of this paper is to shed light on the current landscape of genotyping practices, phenotyping practices and availability of essential vision rehabilitation management for inherited retinal diseases (IRD) in the Asia-Pacific (APAC) Region.
The 62-item questionnaire was distributed electronically via email. The questions covered five domains: (1) structure of the IRD service and registry/database; (2) genotyping practices; (3) genetic counselling; (4) deep phenotyping practices; (5) low-vision rehabilitation services.
The survey was completed by 36 of 45 centres in twelve countries and regions in APAC. Among these centres, 42 % reported managing more than 1000 patients. Notably, 39 % of centres lack an IRD database or registry, and 44 % of centres have tested less than one-quarter of their IRD patients. The majority of centres (67 %) do not have genetic counsellors. While there was consistency in the imaging-based investigations, there was marked heterogeneity for functional testing using electrophysiology and formal perimetry. Only 34 % of centres confirmed the availability of access to low-vision assistive devices.
This study reveals several critical gaps in managing IRDs in the APAC region. These include the lack of IRD database/registry in one-third of centres, a substantial proportion of patients remaining genetically undiagnosed, and limited availability of genetic counsellors. The findings also underscore a need to harmonise investigations for evaluating retinal function and identify areas for improvement in the provision of low-vision rehabilitation services.
本文旨在揭示亚太地区(APAC)在基因分型实践、表型分析实践以及遗传性视网膜疾病(IRD)基本视觉康复管理方面的现状。
通过电子邮件以电子方式分发了 62 项问卷。问题涵盖五个领域:(1)IRD 服务和登记/数据库的结构;(2)基因分型实践;(3)遗传咨询;(4)深度表型分析实践;(5)低视力康复服务。
在 12 个亚太国家和地区的 45 个中心中,有 36 个中心完成了调查。在这些中心中,42%报告管理了超过 1000 名患者。值得注意的是,39%的中心缺乏 IRD 数据库或登记处,44%的中心对不到四分之一的 IRD 患者进行了测试。大多数中心(67%)没有遗传咨询师。虽然基于成像的调查具有一致性,但使用电生理学和正式视野计的功能测试存在明显的异质性。只有 34%的中心确认可以获得低视力辅助设备。
本研究揭示了亚太地区管理 IRD 方面的几个关键差距。其中包括三分之一的中心缺乏 IRD 数据库/登记处,相当一部分患者仍未进行基因诊断,遗传咨询师的可用性有限。研究结果还强调需要协调视网膜功能评估的调查,并确定改善低视力康复服务提供的领域。